Levi & Korsinsky Reminds Grail, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 4, 2026 - GRAL

The Red Flags: What Grail Insiders Allegedly Knew About NHS-Galleri's Insufficient Timeline Before Shareholders Learned the Trial Failed Its Primary Endpoint, Costing Investors $51.32 Per Share The Red Flags: What Grail Insiders Allegedly Knew About NHS-Galleri's Insufficient Timeline Before Shareholders Learned the Trial Failed Its Primary Endpoint, Costing Investors $51.32 Per Share